Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Leapman

Showing results (1-10 of 195) with videos related to

Pageof 20
Sort By:
European Urology Focus|December 2, 2023
Confronting the Climate Emergency in UrologyMichael S Leapman
The Journal of Urology|June 22, 2018
Editorial CommentMichael S Leapman
Urology|December 18, 2024
Editorial Comment on "Commercial Prices and Care for Medicare Beneficiaries With Prostate Cancer"Michael S Leapman
Urology Practice|September 25, 2023
Embracing Challenges and Opportunities Posed by New Technologies in Urologic CareMichael S Leapman
Urology|September 24, 2022
AUTHOR REPLYJames Nie, Michael S Leapman
Urology|April 27, 2016
Editorial CommentMichael S Leapman, Hao G Nguyen
Urologic Oncology|October 18, 2016
What is the best way not to treat prostate cancer?Michael S Leapman, Peter R Carroll
Urology Practice|August 18, 2023
Risk Stratification of Newly Diagnosed Prostate Cancer with Genomic PlatformsMichael S Leapman, Peter R Carroll
Seminars in Radiation Oncology|June 14, 2025
Debate 1: Radical Prostatectomy For the Right Patient With High-Risk Prostate CancerVinaik M Sundaresan, Michael S Leapman
The Urologic Clinics of North America|November 29, 2015
New Genetic Markers for Prostate CancerMichael S Leapman, Peter R Carroll
Pageof 20

Showing results (1-10 of 195) with videos related to

Sort By:
Pageof 20
European Urology Focus|December 2, 2023
Confronting the Climate Emergency in UrologyMichael S Leapman
The Journal of Urology|June 22, 2018
Editorial CommentMichael S Leapman
Urology|December 18, 2024
Editorial Comment on "Commercial Prices and Care for Medicare Beneficiaries With Prostate Cancer"Michael S Leapman
Urology Practice|September 25, 2023
Embracing Challenges and Opportunities Posed by New Technologies in Urologic CareMichael S Leapman
Urology|September 24, 2022
AUTHOR REPLYJames Nie, Michael S Leapman
Urology|April 27, 2016
Editorial CommentMichael S Leapman, Hao G Nguyen
Urologic Oncology|October 18, 2016
What is the best way not to treat prostate cancer?Michael S Leapman, Peter R Carroll
Urology Practice|August 18, 2023
Risk Stratification of Newly Diagnosed Prostate Cancer with Genomic PlatformsMichael S Leapman, Peter R Carroll
Seminars in Radiation Oncology|June 14, 2025
Debate 1: Radical Prostatectomy For the Right Patient With High-Risk Prostate CancerVinaik M Sundaresan, Michael S Leapman
The Urologic Clinics of North America|November 29, 2015
New Genetic Markers for Prostate CancerMichael S Leapman, Peter R Carroll
Pageof 20